Accessing Syria’s healthcare market: A practical guide for medtech companies
Syria’s healthcare system has been reshaped by more than a decade of conflict, economic collapse, and constrained procurement. Public hospitals face severe infrastructure and supply challenges, while private providers and clinicians have adapted in pragmatic, often innovative ways.
This white paper, produced by HealthTechAsia in collaboration with KL MedTech Innovation Advisory™, identifies where credible opportunity and long-term impact now exist for international medtech, health innovation, and investment partners.
Access the full market insight
The white paper consolidates system-level analysis, operational realities, and clinical experience to provide a grounded view of Syria’s healthcare landscape. It covers:
- – Public hospital infrastructure, procurement constraints, and reform dynamics
- – Private sector operations, supply chains, and product quality considerations
- – Market entry pathways, risk factors, and partnership models
- – Practical recommendations for sustainable, long-term engagement
Supporting expert interviews
To complement the report, HealthTechAsia with MedTech Innovation Advisory™ conducted a three-part interview series with stakeholders across the healthcare ecosystem, offering additional context and real-world perspective:
- – Policy & reform – governance challenges and system evolution
- – Market & operations – procurement, distribution, and private sector realities
- – Clinical experience – frontline insight into care delivery and constraints
These interviews underpin the analysis in the white paper and provide readers with on-the-ground nuance.
Syria’s healthcare system under strain—and reinvention
Khaled Bkeirati, Service Manager at Al-Faisaliah Medical Systems, outlines what international healthtech companies need to know before engaging with Syria.